Contact Us Today|

New articles and evidence updates

New articles and evidence updates Trying to stay up to date is tough. New articles and evidence updates don't just find you... right? Let's make staying up to date in the literature a whole lot easier. Who wants to search through journals and pubmed? Nobody. To tons of people, including myself, this task makes staying up to date a chore. What's worse is that it will turn some folks off entirely. How about turning the [...]

By |2019-11-16T16:27:10-05:00November 17th, 2019|Classic EM PharmD|0 Comments

FOAM for emergency medicine pharmacists

FOAM for emergency medicine pharmacists: PharmFOAM Don't waste time searching through updates to see what's new anymore. This is the best way to stay up to date in FOAM and be aware of the latest evidence based medicine updates. I call it PharmFOAM: FOAM for emergency medicine pharmacists. Here's what I'm reading and following today: That's it for PharmFOAM: FOAM for emergency medicine pharmacists! Make sure to click follow to keep up [...]

By |2019-11-16T15:37:07-05:00November 15th, 2019|Classic EM PharmD|0 Comments

Cannabinoid Hyperemesis Syndrome (CHS): Getting “Into the Weeds” on a Complication of Chronic Marijuana Use

Guest post by Evan Mulvihill, PharmD on the hot topic of Cannabinoid Hyperemesis Syndrome

By |2019-07-19T08:09:38-05:00July 19th, 2019|Classic EM PharmD|0 Comments

Single Dose Aminoglycoside For Urinary Tract Infections

Looking for a single dose, no compliance issues, inexpensive, safe, and effective option to treat urinary tract infections? An older therapeutic option might be the answer. A recent systematic review by Goodlet et al. looks into the utility of single dose aminoglycosides (AGs) to treat cysitis.1 Article A Systematic Review of Single-Dose Aminoglycoside Therapy for Urinary Tract Infection: Is It Time To Resurrect an Old Strategy?Kellie J. Goodlet, PharmD , Fatima Z. Benhalima, and Michael [...]

By |2019-06-06T08:00:53-05:00June 6th, 2019|Classic EM PharmD, EM PharmD Blog|0 Comments

I Have Andexanet Issues, 2: A Formulary Toolkit

Zahra Nasrazadani, PharmD, BCPS Emergency Medicine Clinical Pharmacist Salina Regional Health Center A few months ago, Kristina Kipp wrote her inaugural EMCrit article enumerating her (extremely justified) concerns with the data we had available at the time regarding andexanet alfa…or should I say “coagulation factor Xa (recombinant), inactivated-zhzo”(1)? Since then—and in a somewhat perverse order of operations—the drug has been rolled out in a second-generation release and later, the New England Journal of Medicine published [...]

By |2019-04-09T08:10:53-05:00April 9th, 2019|Classic EM PharmD, EM PharmD Blog|0 Comments